A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma
- 1 March 2014
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (5) , 928-936
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2012
- Hepatocellular carcinomaThe Lancet, 2012
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and TherapyAnnual Review of Medicine, 2010
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular CarcinomaGastroenterology, 2009
- Diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology, 2009
- A concise review of serum markers for hepatocellular cancerCancer Detection Prevention, 2007
- Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review. CMEAmerican Journal of Gastroenterology, 2006